Show simple item record

dc.contributor.authorMetsios, George
dc.date.accessioned2020-07-07T11:40:43Z
dc.date.available2020-07-07T11:40:43Z
dc.date.issued2019-05-27
dc.identifier.citationMetsios, G.S. (2019) P0060 Towards optimal intensity, Annals of the Rheumatic Diseases 2019; 78:17.en
dc.identifier.doi10.1136/annrheumdis-2019-eular.8537en
dc.identifier.urihttp://hdl.handle.net/2436/623331
dc.description.abstractBackground: There is ample evidence now to suggest that exercise can help ameliorate RMD symptoms and comorbidities. Similar to the prescription of medication, the dosage of exercise should be optimized to achieve the best health benefits. However, a consensus on the dosage of exercise prescription for RMD patients is currently missing. Objectives: This talk will explore the data required from RMD patients to develop the best exercise prescription, exercise principles and current state-of-the-art, as well as how we can use the current evidence to identify the optimum dosage for the exercise prescription in people with RMDs. Methods: Suggestions have been synthesized using existing evidence-based resources, including recent systematic reviews and meta-analyses (EULAR, Cochrane Library and peer-reviewed journals publications) as well as randomized controlled trials. Data for the effectiveness of exercise dosage on various different outcomes has been extracted and will be explored. Results: Different dosages of exercise have differing effects on symptoms of RMDs. The optimal dosage depends on various factors and on the outcome that the exercise prescription aims to improve. Conclusion: Despite the increasing research on exercise in RMDs, a currently a consensus for the optimal exercise dosage is currently missing. More interdisciplinary research, with a heavy patient involvement, is required in the area. Disclosure of Interests: None declareden
dc.formatapplication/vnd.openxmlformats-officedocument.presentationml.presentationen
dc.language.isoenen
dc.publisherBMJ Publishing Group Ltd and European League Against Rheumatismen
dc.relation.urlhttps://ard.bmj.com/content/78/Suppl_2/17.1en
dc.titleTowards optimal intensityen
dc.typePresentationen
dc.identifier.eissn1468-2060
dc.identifier.journalAnnals of the Rheumatic Diseasesen
dc.date.updated2020-06-27T08:18:49Z
dc.conference.nameAnnual European Congress of Rheumatology, EULAR 2019
dc.conference.locationMadrid, Spain
pubs.finish-date2019-06-15
pubs.start-date2019-06-12
rioxxterms.funderUniversity of Wolverhamptonen
rioxxterms.identifier.projectUOW07072020GMen
rioxxterms.versionAMen
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc/4.0/en
rioxxterms.licenseref.startdate2020-07-07en
dc.source.volume78
dc.source.beginpage17
dc.source.endpage17
dc.description.versionPublished version
refterms.dateFCD2020-07-07T11:34:46Z
refterms.versionFCDAM
refterms.dateFOA2020-07-07T11:40:44Z


Files in this item

Thumbnail
Name:
EULAR 2019 Metsios.pptx
Size:
2.753Mb
Format:
Unknown

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc/4.0/